GSK-3β, human recombinant protein
GSK, Glycogen synthase kinase-3 (GSK-3)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P49841 |
---|---|
Calculated MW | 53.0-56.0 kDa |
Gene ID | 2932 |
---|---|
Gene Symbol | GSK3B |
Other Names | GSK, Glycogen synthase kinase-3 (GSK-3) |
Gene Source | Human |
Source | E.coli |
Assay&Purity | SDS-PAGE; ≥90% |
Assay2&Purity2 | HPLC; |
Recombinant | Yes |
Application Notes | Reconstitute to 1 mg/ml in PBS containing 15% glycerol. The solution should be stored at –70°C, stable for up to 3 months. |
Format | Lyophilized powder |
Storage | -70°C; Lyophilized from 2 mg/ml in 0.1 M NH4CO3 |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Glycogen synthase kinase-3 (GSK-3) is a serine/theronine kinase that was first characterized by its role in intermediary metabolism. In mammals, serine kinase is encoded by two related genes called GSK-3α (51 kDa) and GSK-3β (46 kDa). GSK-3 has been implicated in the regulation of the c-JuP-1 transcription factor and other intracellular signaling pathways.
References
Stambolic V.,et al.Biochem. J. 303:701-704(1994).
Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
Lau K.F.,et al.Genomics 60:121-128(1999).
Rhoads A.R.,et al.Mol. Psychiatry 4:437-442(1999).
Boyle W.J.,et al.Cell 64:573-584(1991).

If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.